Neil O'Neill Gilmore, CEO at Editas Medicine, Inc. (EDIT), sold 155,648 shares at $9.42 ($1.5M) on 2024-03-05, disclosed to the SEC on 2024-03-05.
Scheduled sale ($1.5M) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.42 | 77,824 | $733K | 50.0% |
| 2 | $9.42 | 77,824 | $733K | 50.0% |
| Total | $9.42 avg | 155,648 | $1.5M | 100% |
| Filing → |
| EDIT | SELL | 2026-03-04 | $11K | — | Filing → |
| EDIT | SELL | 2025-12-04 | $12K | — | Filing → |
| EDIT | SELL | 2025-09-04 | $15K | — | Filing → |